Cathepsin S 抗体
(Cathepsin S (CTSS))
The protein encoded by this gene, a member of the peptidase C1 family, is a lysosomal cysteine proteinase that may participate in the degradation of antigenic proteins to peptides for presentation on MHC class II molecules. The encoded protein can function as an elastase over a broad pH range in alveolar macrophages. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Dec 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Cathepsin S 抗体 (AA 115-331) | 人 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 115-331) | Cow | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 123-339) | 小鼠 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 210-240) | 人 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 | 人 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 115-331) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant Cathepsin S 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Cathepsin S 抗体 (AA 17-331) | 人 | 小鼠 Monoclonal |
|
|
|
| Cathepsin S 抗体 | 人, 小鼠 | 小鼠 Monoclonal |
|
|
|
| Cathepsin S 抗体 (AA 1-331) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant Cathepsin S 抗体 | 人 | Human Monoclonal |
|
|
|
| Cathepsin S 抗体 (N-Term) | 人, Cow, 马, Pig, 猴 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 113-330) | 大鼠 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 1-331) | 人 | 小鼠 Polyclonal |
|
|
|
| Cathepsin S 抗体 (HRP) | 人 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 123-339) (Biotin) | 小鼠 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 1-331) | 人 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (FITC) | 人 | 兔 Polyclonal |
|
|
|
| Cathepsin S 抗体 (AA 123-339) (FITC) | 小鼠 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 115-331
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- Cow
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 115-331
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 123-339
Primary Antibody
- WB (Western Blotting: 有验证图片)
- FACS (Flow Cytometry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 克隆
- RB19262
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 210-240
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 115-331
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 9B10
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IF (Immunofluorescence: 有验证图片)
- ELISA (ELISA: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- AT1F9
- 标记
- unconjugated
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 17-331
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- ELISA (ELISA: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- unconjugated
- 抗体亚型
- IgG2b
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-331
Primary Antibody
- SDS (SDS-PAGE: 有验证图片)
- SEC-HPLC (Size-exclusion chromatography-High Pressure Liquid Chromatography: 有验证图片)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- BLI (Bio-Layer Interferometry: 所列应用)
- Func (Functional Studies: 所列应用)
- SPR (Surface Plasmon Resonance: 所列应用)
- 适用
- 人
- 宿主
- Human
- 克隆形成能力
- Monoclonal
- 克隆
- Fsn0503h
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1
Primary Antibody
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人, Cow, 马, Pig, 猴
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 113-330
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-331
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 123-339
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-331
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 123-339
Latest Publications for our Cathepsin S 抗体
: "Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats." in: PLoS ONE, Vol. 10, Issue 2, pp. e0118655, (2015) (PubMed).
: "Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism." in: Nature, Vol. 524, Issue 7565, pp. 361-5, (2015) (PubMed).
: "Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 188, Issue 1, pp. 68-76, (2011) (PubMed).
: "Diminished intracellular invariant chain expression after vaccinia virus infection." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 183, Issue 3, pp. 1542-50, (2009) (PubMed).
: "Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes." in: Blood, Vol. 111, Issue 4, pp. 2339-46, (2008) (PubMed).
: "Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years." in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, Vol. 14, Issue 4, pp. 460-8, (2007) (PubMed).
: "Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women." in: The Journal of clinical endocrinology and metabolism, Vol. 91, Issue 3, pp. 1042-7, (2006) (PubMed).
: "Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism." in: Nature, Vol. 524, Issue 7565, pp. 361-5, (2015) (PubMed).
: "Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 188, Issue 1, pp. 68-76, (2011) (PubMed).
: "Diminished intracellular invariant chain expression after vaccinia virus infection." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 183, Issue 3, pp. 1542-50, (2009) (PubMed).
: "Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes." in: Blood, Vol. 111, Issue 4, pp. 2339-46, (2008) (PubMed).
: "Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years." in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, Vol. 14, Issue 4, pp. 460-8, (2007) (PubMed).
: "Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women." in: The Journal of clinical endocrinology and metabolism, Vol. 91, Issue 3, pp. 1042-7, (2006) (PubMed).
Aliases for Cathepsin S 抗体
cathepsin S (CTSS) 抗体cathepsin S (Ctss) 抗体
cathepsin S L homeolog (ctss.L) 抗体
cathepsin S S homeolog (ctss.S) 抗体
cathepsin S (ctss) 抗体
Cathepsin S (cats) 抗体
cats 抗体
CTSS 抗体
ctss 抗体
ctss-a 抗体
ctss-b 抗体
ctss.1 抗体
MGC69026 抗体
MGC80097 抗体
您还需要查找其他产品吗？
- Cathepsin L2 抗体
- Cathepsin L1 抗体
- Cathepsin K 抗体
- Cathepsin H 抗体
- Cathepsin G 抗体
- Cathepsin F 抗体
- Cathepsin E 抗体
- Cathepsin D 抗体
- Cathepsin B 抗体
- Cathepsin 7 抗体
- Cathelicidin 抗体
- Catechol-O-Methyltransferase 抗体
- Catalase 抗体
- CASZ1 抗体
- CASS4 抗体
- CASR 抗体
- CASQ2 抗体
- Caspase Activity and Apoptosis Inhibitor 1 抗体
- Caspase 9 抗体
- Caspase 8 抗体
You are here:
